VIRINCHIVirinchi Limited
IT · Software - Application · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Virinchi Limited provides information technology (IT) products and services worldwide. The company operates through Development of Computer Software and Services, IT Enabled Services, and Healthcare Services segments. It offers QFund, an IT solution for short-term mortgage and lending industry; vCard, an UPI-based credit card; V23, a healthcare practice management and patient engagement solution; KSoft, provides IT services, such as lifecycle management, ECM services, IT infrastructure management, and IT staff augmentation and consulting services; software development; and data science and analysis services. The company also offers media and entertainment, catering, educational, infrastructure, pharmacy supply chain, fintech, healthcare, and financial consulting services. Further, it owns and manages Bristlecone Hospital, a specialty hospital. The company was formerly known as Virinchi Technologies Limited and changed its name to Virinchi Limited in January 2016. Virinchi Limited was incorporated in 1990 and is headquartered in Hyderabad, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on VIRINCHI — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why avoid
- • Overall evidence is weak (AlgoScore 20/100)
- • Revenue growth: -12.0% YoY
- • Profit growth: 0.0% YoY
- • RSI: 37
- • MACD: bearish
Bull case
- • Debt/Equity: 0.57
- • Volume trend: 1.6x baseline
- • Beta: 0.79
Bear case
- • Revenue growth: -12.0% YoY
- • Profit growth: 0.0% YoY
- • RSI: 37
- • MACD: bearish
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • Weak fundamentals — technical strength may not sustain
- • Momentum is fading versus the broader market
- • Revenue growth: -12.0% YoY
- • Profit growth: 0.0% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹0.68). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.